Ventas, Inc. logo VTR - Ventas, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 18
HOLD 12
SELL 2
STRONG
SELL
0
| PRICE TARGET: $99.43 DETAILS
HIGH: $110.00
LOW: $88.00
MEDIAN: $100.00
CONSENSUS: $99.43
UPSIDE: 8.06%
AlphaVal

AlphaVal

Deterministic, archetype-aware fair value

Real Estate Investment Trust 85% confidence

Primary model: P/FFO × Healthcare REIT Multiple

Valuation Signal Overvalued Strong
Trading 68.0% above fair value
Current Price $92.01
Bear Case $43.35 52.9% downside ($43.35 - $92.01) / $92.01 = -52.9% $3.35 FFO × 15x
Fair Value $54.76 40.5% downside ($54.76 - $92.01) / $92.01 = -40.5% $3.35 FFO × 19x
Bull Case $66.18 28.1% downside ($66.18 - $92.01) / $92.01 = -28.1% $3.35 FFO × 23x

Adjust Assumptions

18.9x
3.35$

Key Value Driver

FFO/share ($3.35) × healthcare P/FFO multiple

Implied Market Multiple 27.4x

Plain-Language Summary

At $3.35 FFO/share with a 19x healthcare REIT multiple, the base-case value is $54.76 per share. Dividend yield: 2.2%. DDM cross-check: $34.79.

Analyst Consensus (External Reference)

Never blended into the bear/base/bull estimates above -- shown only as an outside comparison.

Average Target (32 analysts) $99.43
Analyst Range $88.00 – $110.00
Divergence from AlphaVal 45%

Warnings

Standard profit figures are misleading for real estate companies — large non-cash accounting charges make profits look artificially low. Dividend yield and funds from operations are better measures.
Dividend-based valuation: $34.79 (36% below our primary estimate). Large gaps suggest the dividend may not fully reflect the company's value.
Wall Street's average price target is $99.43 (from 32 analysts). Our estimate is 45% below the consensus -- consider that gap carefully.

Key Risks

  • P/E and EV/EBITDA are structurally wrong for REITs — use P/FFO and NAV
  • Interest rate sensitivity: REIT multiples compress when rates rise
  • FFO approximation (NI + D&A) may include gains on property sales — verify